Trials / Unknown
UnknownNCT03383068
Research of Intensive Metabolic Intervention Before Pregnancy in PCOS
Research of Intensive Metabolic Intervention Before Pregnancy in Polycystic Ovary Syndrome
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 160 (estimated)
- Sponsor
- RenJi Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
To investigate whether intensive metabolic intervention of PCOS women before pregnancy can improve pregnancy outcome.Besides, the investigators aim to investigate the best therapy strategy of metabolic intervention before pregnancy.The investigators plan to recruit PCOS women at childbearing age. By using acarbose, GLP-1 analogue, berberin et al. the investigators will intervent the participants' metabolic statues for 3 months before pregnancy and to compare outcome in each group.
Detailed description
To investigate whether intensive metabolic intervention of PCOS women before pregnancy can improve pregnancy outcome.Besides, the investigators aim to investigate the best therapy strategy of metabolic intervention before pregnancy.The investigators plan to recruit PCOS women with IGR / DM not effective of metformin treatment at childbearing age. By using acarbose, GLP-1 analogue, berberin et al. the investigators will intervent the participants' metabolic statues for 3 months before pregnancy and to compare outcome in each group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Acarbose 100 MG | for metformin uneffective subjects, using acarbose for 3 months |
| DRUG | Exenatide | for metformin uneffective subjects, using Exenatide for 3 months |
| DRUG | Orlistat | for metformin uneffective subjects, using Orlistatfor 3 months |
| DRUG | Metformin | metformin effective subjects,act as control group |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2018-12-31
- Completion
- 2020-06-30
- First posted
- 2017-12-26
- Last updated
- 2017-12-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03383068. Inclusion in this directory is not an endorsement.